Skip to main content
. 2016 Oct;11(4):214–223.

Table2.

Determinants of Depressive Symptoms in the Recruited Patients of the Study (n = 770)*

Non-Depressed (n = 470) Depressed (n=300) P Value
Age (y) 44.83±5.70 46.14±5.75 0.002
Sex < 0.001
Male 256 (54.5) 111 (37.0)
Female 214 (45.5) 189 (63.0)
Risk Factors
Positive Family History 198 (42.1) 149 (49.7) 0.040
Hypertension 211 (44.9) 155 (51.7) 0.066
Hyperlipidemia 340 (72.3) 215 (71.7) 0.839
Diabetes Mellitus 146 (31.3) 111 (37.0) 0.088
Cigarette Smoking 171 (36.4) 94 (31.3) 0.150
Opium Usage 42 (8.9) 35 (11.7) 0.218
No Risk Factor 18 (3.8) 11 (3.7) 0.908
BMI (kg/m2) 28.66±4.47 30.11±5.22 < 0.001
BMI Categories 0.015
Underweight 1 (0.2) 1 (0.3)
Normal 91 (19.4) 42 (14.0)
Overweight 217 (46.2) 121 (40.3)
Obese 161 (34.3) 136 (45.3)
Creatinine(mg/dl) 0.95±0.22 0.92±0.23 0.072
EF (%) 52.90±10.00 52.81±9.81 0.912
Abdominal Circumference (cm) 98.32±11.48 99.90±12.16 0.074
Recent MI 215 (45.7) 127 (42.3) 0.353
No of Involved Vessels 0.379
SVD 211 (44.9) 145 (48.3)
2VD 125 (26.6) 83 (27.7)
3VD 134 (28.5) 72 (24.0)
Left Main Coronary Involvement 7 (1.5) 4 (1.3) 0.859
Initial Treatment 0.776
Medical Treatment 145 (30.9) 93 (31.0)
PCI 217 (46.2) 132 (44.0)
CABG 108 (23.0) 75 (25.0)
MACE 80 (17.0) 72 (24.0) 0.018
Duration of F/U (mo) 59.34±22.24 62.14±65.37 0.394

BMI, Body mass index; EF, Ejection fraction; MI, Myocardial infarction; SVD, Single-vessel disease; 2VD, Two-vessel disease; 3VD, Three-vessel disease; PCI, Percutaneous coronary intervention; CABG, Coronary artery bypass grafting; MACE, Major cardiac adverse events; F/U, Follow-up

*

Data are presented as mean± SD or n (%)